BBOT NASDAQ · Healthcare · FY 2025-12-31

BridgeBio Oncology Therapeutics, Inc.

0.02.24.46.68.7ABVfair 5.14buy ≤ 1.28EPVnot valid for this companyEBVnot valid for this companyDBVnot valid for this companyprice 8.09 USD
ABV EPV EBV DBV fair value / share buy at or below (margin of safety applied) margin-of-safety band current price values in USD
Verdict
Avoid
Buy zone
Overvalued
Archetype
Distressed/Deficit
Confidence
●○○ Low · 1/4

Price
8.090 USD
Market cap
647.1M USD
P / B
1.57
P / E
EPS
-4.300
DPS / yield
(0.0%)
NAV / share
5.139
Graham number
Z'' score
12.61
Piotroski F
3 / 9
Beneish M
ROIC vs WACC
-330.3% vs 7.0%

See the full orchestrator pipeline — solvency gate, lens cascade, reconciliation, archetype, decision, and confidence.

Subscribe to unlock this and every other tab for every company.

See the full ABV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EPV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full DBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.